Journal of the American Chemical Society
Page 8 of 9
intramolecular allylic amination reactions. Chem. Eur. J.
2009, 15, 11078.
cerevisiae chitin synthase isozyme Chs3 in vitro and in
vivo. J Bacteriology. 1994, 176, 5857.
1
2
3
4
5
6
7
8
(3) Kochi, T.; Tang, T. P.; Ellman, J. A. Development and
application of a new general method for the asymmetric
synthesis of syn- and anti-1,3-amino alcohols. J. Am.
Chem. Soc. 2003, 125, 11276.
(4) (a) Keck, G. E.; Truong, A. P. Directed reduction of β-
amino ketones to syn or anti 1,3-amino alcohol derivatives.
Org, Lett. 2002, 4, 3131. (b) Davis, F. A.; Gaspari, P. M.; Nolt,
B. M.; Xu, P. Asymmetric synthesis of acyclic 1,3-amino
alcohols by reduction of N-sulfinyl β-amino ketones.
Formal synthesis of (−)-Pinidinol and (+)- Epipinidinol. J.
Org. Chem. 2008, 73, 9619.
(5) Broustal, G.; Ariza, X.; Campagne, J.-M.; Garcia, J.;
Georges, Y.; Marinetti, A.; Robiette, R. A stereoselective
approach to 1,3-amino alcohols protected as cyclic
carbamates: kinetic vs. thermodynamic control. Eur. J. Org.
Chem. 2007, 4293.
(6) Spreider, P. A.; Haydl, A. M.; Heinrich, M.; Breit, B.
Rhodium-catalyzed diastereoselective cyclization of
allenyl-sulfonylcarbamates: A stereodivergent approach to
1,3-aminoalcohol derivatives. Angew. Chem. Int. Ed. 2016,
55, 15569.
(7) (a) Chen, M. S.; Prabagaran, N.; Labenz, N. A.; White, M.
C. Serial ligand catalysis: a highly selective allylic C-H
oxidation. J. Am. Chem. Soc. 2005, 127, 6970. (b)
Fraunhoffer, K. J.; White, M. C. syn-1,2-Amino alcohols via
diastereoselective allylic C-H amination. J. Am. Chem. Soc.
2007, 129, 7274.
(8) (a) Ammann, S. E.; Liu, W.; White, M. C. Enantioselective
allylic C-H oxidation of terminal olefins to isochromans by
palladium(II)/chiral sulfoxide catalysis. Angew. Chem., Int.
Ed. 2016, 55, 9571. (b) Liu, W.; Ali, S. Z.; Ammann, S. E.;
White, M. C. Asymmetric allylic C-H alkylation via
palladium(II)/ cis-ArSOX catalysis. J. Am. Chem. Soc. 2018,
140, 10658.
(15) Stoner, E. J.; Cooper, A. J.; Dickman, D. A.;
Kolaczkowski, L.; Lallaman, J. E.; Liu, J.-H.; Oliver-Shaffer, P.
A.; Patel, K. M.; Paterson, J. B.; Plata, D. J.; Riley, D. A.; Sham,
H. L.; Stengel, P. J.; Tien, J.-H. Synthesis of HIV protease
inhibitor ABT-378 (Lopinavir). Org. process Res. Dev. 2000,
4, 264.
(16) Kempf, D. J.; Sham, H. L.; Marsh, K. C.; Flentge, C. A.;
Betebenner, D.; Green, B. E.; McDonald, E.; Vasavanonda,
S.; Saldivar, A.; Wideburg, N. E.; Kati, W. M.; Ruiz, L.; Zhao,
C.; Fino, L.; Patterson, J.; Molla, A.; Plattner, J. J.; Norbeck,
D. W. Discovery of ritonavir, a potent inhibitor of HIV
protease with high oral bioavailability and clinical efficacy.
J. Med. Chem. 1998, 41, 602.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(17) Kondo, S.; Shibahara, S.; Takahashi, S.; Maeda, K.;
Umezawa, H.; Ohno, M. Negamycin, a novel hydrazide
antibiotic. J. Am. Chem. Soc. 1971, 93, 6305.
(18) (a) Jensen, D. R.; Pugsley, J. S.; Sigman, M. S.
palladium-catalyzed
enantioselective
oxidations
of
alcohols using molecular oxygen. J. Am. Chem. Soc. 2001,
123, 7475. (b) Ferreira, E. M.; Stoltz, B. M. The Palladium-
catalyzed oxidative kinetic resolution of secondary
alcohols with molecular oxygen. J. Am. Chem. Soc. 2001,
123, 7725.(c) Werner, E. W.; Mei, T. S.; Burckle, A. J.;
Sigman, M. S. Enantioselective Heck arylations of acyclic
alkenyl alcohols using a redox-relay strategy. Science.
2012, 338, 1455. (d) Wang, D.; Weinstein, A. B.; White, P.
B.; Stahl, S. S. Ligand-promoted palladium-catalyzed
aerobic oxidation reactions. Chem. Rev. 2018, 118, 2636.
(19) Watanabe, M,; Asano, R.; Nagasawa, K.; Uesugi, M.
Vitamin D3 derivatives and pharmaceutical use thereof.
WO2016103722A1. 2016.
(20) (a) Nyasse, B.; Grehn, L.; Ragnarsson, U. Mild, efficient
cleavage of arenesulfonamides by magnesium reduction.
Chem. Commun. 1997, 1017. Tolerance for reducible
functionality see: (b) Guo, L. D.; Huang, X. Z.; Luo, S. P.;
Cao, W. S.; Ruan, Y. P.; Ye, J. L.; Huang, P. Q.
Organocatalytic, asymmetric total synthesis of (-)-
haliclonin A. Angew. Chem., Int. Ed. 2016, 55, 4064.
(9) Ma, R.; White, M. C. C-H to C-N cross-coupling of
sulfonamides with olefins. J. Am. Chem. Soc. 2018, 140,
3202.
(10) DFT studies examining the anti/syn equilibrium in
isopropyl and phenyl substituted N-tosyl oxazinanones
anti-1a/syn-1b and anti-2/syn-2 consistently show a
higher stability of the anti. See references 5 and 6.
(11) Pattillo, C. C.; Strambeanu, I. I; Calleja, P.; Vermeulen,
N. A.; Mizuno, T.; White, M. C. Aerobic linear allylic C-H
amination: overcoming benzoquinone inhibition. J. Am.
Chem. Soc. 2016, 138, 1265.
(12) Ueno, M.; Huang, Y. Y.; Yamano, A.; Kobayashi, S.
Revised stereochemistry of ceramide-trafficking inhibitor
HPA-12 by X-ray crystallography analysis. Org. Lett. 2013,
15, 2869.
(13) Hootele, C.; Colau, B.; Halin, F. Sedum alkaloids II:
sedacryptine, a new minor base from sedum acre.
Tetrahedron Lett. 1980, 21, 5061.
(14) Gaughran, J. P.; Lai, M. H.; Kirsch, D. R.; Silverman, S. J.
Nikkomycin Z is a specific inhibitor of Saccharomyces
(21)(a) Våbenø, J.; Brisander, M.; Lejon, T.; Luthman, K.
Diastereoselective reduction of a chiral N-Boc-protected
δ-amino-α,
β-unsaturated
γ-keto
ester
Phe-Gly
dipeptidomimetic. J. Org. Chem. 2002, 67, 9186. (b)
Mikkelsen, L. M.; Jensen, C. M.; Høj, B.; Blakskjær, P.;
Skrydstrup, T. Further studies in the acyl-type radical
additions promoted by SmI2: mechanistic implications and
stereoselective reduction of the keto-functionality.
Tetrahedron. 2003, 59, 10541.
(22) (a) Ghosh, A. K.; McKee, S. P.; Thompson, W. J.; Darke,
P. L.; Zugay, J. C. Potent HIV-1 protease inhibitors:
stereoselective synthesis of a dipeptide mimic. J. Org.
Chem. 1993, 58, 1025. (b) Baker, W. R.; Pratt, J. K.
Dipeptide isosteres. 2. Synthesis of hydroxyethylene
dipeptide isostere diastereomers from a common γ-
lactone intermediate. Preparation of renin and HIV-1
8
ACS Paragon Plus Environment